G1 Therapeutics
GTHX
$4.49
Share price
1.13%
Change (1 day)
42.99%
Change (1 year)
Categories
Revenue for G1 Therapeutics (GTHX)
Revenue in 2023 (TTM): $82.51 M
According to G1 Therapeutics
's latest financial reports the company's current revenue (TTM
) is $82.51 M.
In 2022 the company made a revenue of $51.3 M an increase over the years 2021 revenue that were of $31.47 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for G1 Therapeutics from 2016 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $82.51 M | 60.84% |
| 2022 | $51.3 M | 62.98% |
| 2021 | $31.47 M | -30.49% |
| 2020 | $45.28 M | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |